» Articles » PMID: 35002950

Syndrome Differentiation and Treatment Regularity in Traditional Chinese Medicine for Type 2 Diabetes: A Text Mining Analysis

Overview
Specialty Endocrinology
Date 2022 Jan 10
PMID 35002950
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The goal of this study was to systematically summarize and categorize the syndrome differentiation, medication rules, and acupoint therapy in the domestic traditional Chinese medicine (TCM) literature on type 2 diabetes mellitus (T2DM), such that guidelines and new insights can be provided for future practitioners and researchers.

Methods: Taking randomized controlled trials (RCTs) on the treatment of T2DM in TCM as the research theme, we searched for full-text literature in three major clinical databases, including CNKI, Wan Fang, and VIP, published between 1990 and 2020. We then conducted frequency statistics, cluster analysis, association rules extraction, and topic modeling based on a corpus of medical academic words extracted from 3,654 research articles.

Results: The TCM syndrome types, subjective symptoms, objective indicators, Chinese herbal medicine, acupuncture points, and TCM prescriptions for T2DM were compiled based on invigorating the kidney and , nourishing , and strengthening the spleen. Most TCM syndrome differentiation for T2DM was identified as "" (the lesion in the spleen and stomach) and "" (the lesion in the kidney) deficiency syndromes, and most medications and acupoint therapies were focused on the "Spleen Channel" and "Kidney Channel." However, stagnation of liver was mentioned less when compared with other syndromes, which did not have symptomatic medicines.

Conclusion: This study provides an in-depth perspective for the TCM syndrome differentiation, medication rules, and acupoint therapy for T2DM and provides practitioners and researchers with valuable information about the current status and frontier trends of TCM research on T2DM in terms of both diagnosis and treatment.

Citing Articles

Perceptions and Attitudes of People With Cancer and Diabetes Towards Patient Guidelines: A Mixed Methods Study.

Yan L, Liang N, Yu Z, Cook L, Scott S, Graham K Health Expect. 2025; 28(1):e70164.

PMID: 39876598 PMC: 11775387. DOI: 10.1111/hex.70164.


Exploring the potential anti-diabetic peripheral neuropathy mechanisms of Huangqi Guizhi Wuwu Decoction by network pharmacology and molecular docking.

Zhang X, Zhong G, Jiang C, Ha X, Yang Q, Wu H Metab Brain Dis. 2024; 40(1):20.

PMID: 39565454 DOI: 10.1007/s11011-024-01474-w.


Evaluation of the effect of full-process blood glucose management on T2DM cataract patients based on visual electrophysiology and OCTA.

Tang J, Li T, Wang X, Xue H, Zhang D, Liu X Sci Rep. 2024; 14(1):27862.

PMID: 39537656 PMC: 11560918. DOI: 10.1038/s41598-024-76510-x.


AI empowering traditional Chinese medicine?.

Song Z, Chen G, Chen C Chem Sci. 2024; .

PMID: 39355231 PMC: 11440359. DOI: 10.1039/d4sc04107k.


Matching traditional Chinese medicine and western medicine-based research: Advanced nutraceutical development for proactive gastric cancer prevention.

Micucci M, Xiang B, Ting C, Kwan H, Mari M, Retini M World J Gastrointest Oncol. 2024; 16(9):3798-3819.

PMID: 39350981 PMC: 11438774. DOI: 10.4251/wjgo.v16.i9.3798.


References
1.
Holman N, Young B, Gadsby R . Current prevalence of Type 1 and Type 2 diabetes in adults and children in the UK. Diabet Med. 2015; 32(9):1119-20. DOI: 10.1111/dme.12791. View

2.
Zheng Y, Ley S, Hu F . Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2017; 14(2):88-98. DOI: 10.1038/nrendo.2017.151. View

3.
Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H . Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020; 369:m997. PMC: 7186854. DOI: 10.1136/bmj.m997. View

4.
Song Y, Zhao B, Jia J, Wang X, Xu S, Li Z . A Review on Different Kinds of Artificial Intelligence Solutions in TCM Syndrome Differentiation Application. Evid Based Complement Alternat Med. 2021; 2021:6654545. PMC: 7963904. DOI: 10.1155/2021/6654545. View

5.
Tuomilehto J, Lindstrom J, Eriksson J, Valle T, Hamalainen H, Ilanne-Parikka P . Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344(18):1343-50. DOI: 10.1056/NEJM200105033441801. View